
Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities research analysts at Cormark dropped their FY2025 earnings per share estimates for Green Thumb Industries in a research report issued on Monday, August 11th. Cormark analyst J. Pytlak now anticipates that the company will earn $0.06 per share for the year, down from their prior forecast of $0.10. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of $0.04 by ($0.05). The firm had revenue of $293.26 million for the quarter, compared to analysts' expectations of $280.66 million. Green Thumb Industries had a net margin of 2.51% and a return on equity of 1.62%.
Separately, Benchmark restated a "buy" rating on shares of Green Thumb Industries in a research report on Monday, August 11th.
Read Our Latest Research Report on Green Thumb Industries
Green Thumb Industries Price Performance
Green Thumb Industries stock traded down $1.07 during mid-day trading on Tuesday, reaching $7.56. 1,264,217 shares of the stock traded hands, compared to its average volume of 854,068. The stock has a market capitalization of $1.60 billion, a PE ratio of 68.73 and a beta of 1.18. Green Thumb Industries has a 12-month low of $4.63 and a 12-month high of $12.00. The business's 50-day moving average is $6.01 and its 200-day moving average is $6.04.
Green Thumb Industries Company Profile
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Further Reading

Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.